Correlation Between C4 Therapeutics and Edgewise Therapeutics
Can any of the company-specific risk be diversified away by investing in both C4 Therapeutics and Edgewise Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining C4 Therapeutics and Edgewise Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between C4 Therapeutics and Edgewise Therapeutics, you can compare the effects of market volatilities on C4 Therapeutics and Edgewise Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in C4 Therapeutics with a short position of Edgewise Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of C4 Therapeutics and Edgewise Therapeutics.
Diversification Opportunities for C4 Therapeutics and Edgewise Therapeutics
0.72 | Correlation Coefficient |
Poor diversification
The 3 months correlation between CCCC and Edgewise is 0.72. Overlapping area represents the amount of risk that can be diversified away by holding C4 Therapeutics and Edgewise Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Edgewise Therapeutics and C4 Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on C4 Therapeutics are associated (or correlated) with Edgewise Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Edgewise Therapeutics has no effect on the direction of C4 Therapeutics i.e., C4 Therapeutics and Edgewise Therapeutics go up and down completely randomly.
Pair Corralation between C4 Therapeutics and Edgewise Therapeutics
Given the investment horizon of 90 days C4 Therapeutics is expected to generate 1.22 times more return on investment than Edgewise Therapeutics. However, C4 Therapeutics is 1.22 times more volatile than Edgewise Therapeutics. It trades about 0.05 of its potential returns per unit of risk. Edgewise Therapeutics is currently generating about -0.2 per unit of risk. If you would invest 385.00 in C4 Therapeutics on October 20, 2024 and sell it today you would earn a total of 9.00 from holding C4 Therapeutics or generate 2.34% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
C4 Therapeutics vs. Edgewise Therapeutics
Performance |
Timeline |
C4 Therapeutics |
Edgewise Therapeutics |
C4 Therapeutics and Edgewise Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with C4 Therapeutics and Edgewise Therapeutics
The main advantage of trading using opposite C4 Therapeutics and Edgewise Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if C4 Therapeutics position performs unexpectedly, Edgewise Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Edgewise Therapeutics will offset losses from the drop in Edgewise Therapeutics' long position.C4 Therapeutics vs. Shattuck Labs | C4 Therapeutics vs. Prelude Therapeutics | C4 Therapeutics vs. Monte Rosa Therapeutics | C4 Therapeutics vs. Foghorn Therapeutics |
Edgewise Therapeutics vs. Century Therapeutics | Edgewise Therapeutics vs. C4 Therapeutics | Edgewise Therapeutics vs. Mineralys Therapeutics, Common | Edgewise Therapeutics vs. Cullinan Oncology LLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Other Complementary Tools
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |